Histocultures and Their Use

Abstract

Histocultures are three‐dimensional tissues that are put into growth medium either with a collagen gel support or simply free floating. Histocultures maintain their in vivo‐like phenotype in contrast to monolayer cultures. Histocultures have many uses, including culture and sensitivity testing of patient tumour to choose optimal individualised treatment. Clinical trials have demonstrated the clinical utility of the histoculture drug response assay (HDRA) to determine effective treatment for multiple types of cancer. The histoculture of skin to study hair growth and screen drugs that enhance or inhibit hair growth has enabled the discovery of hair follicle‐targeting cancer liposomes to deliver genes and other molecules to the hair follicles. The histoculture of lymphoid organs has been developed to study antibody production and effects of viruses on immune cells. Stem cell growth and differentiation are now being studied in histoculture.

Key Concepts:

  • Histocultures are the culture of intact tissues containing multiple cell types.

  • Histocultures retain their in vivo phenotype in contrast to monolayer cultures.

  • Histocultured tumour tissue contains cancer cells and stromal elements interacting with each other in their native structure.

  • Histocultured tumours can be tested for drug sensitivity to design effective individualised therapy for each patient.

  • Histocultured lymphoid tissue can enable the study of antibody production and virus infection in vitro.

  • Histocultured skin enables hair growth in vitro.

  • Histocultured stem cells cancer differentiates in vitro.

Keywords: histology; three‐dimensional tissue culture; tumours; chemosensitivity; lymph nodes; immune function; skin; hair growth; stem cells; differentiation

Figure 1.

Histoculture of nestin GFP‐expressing hair follicle stem cells on Gelfoam®.

close

References

Abbott A (2003) Biology's new dimension. Nature 424: 870–872.

Chishima T, Miyagi Y, Li L et al. (1997b) Use of histoculture and green fluorescent protein to visualize tumor cell host interaction. In vitro Cellular & Developmental Biology 33: 745–747.

Chishima T, Yang M, Miyagi Y et al. (1997a) Governing step of metastasis visualized in vitro. Proceedings of the National Academy of Sciences of the USA 94: 11573–11576.

Furukawa T, Kubota T and Hoffman RM (1995) Clinical applications of the histoculture drug response assay. Clinical Cancer Research 1: 305–311.

Geller J, Sionit LR, Connors KM and Hoffman RM (1992) Measurement of androgen sensitivity in the human prostate in in vitro three‐dimensional histoculture. Prostate 21: 269–278.

Glushakova S, Baibakov B, Margolis LB and Zimmerberg J (1995) Infection of human tonsil histocultures: a model for HIV pathogenesis. Nature Medicine 1: 1320–1322.

Grivel JC and Margolis L (2009) Use of human tissue explants to study human infectious agents. Nature Protocols 4: 256–269.

Hoffman RM (2009) Hair follicle pluripotent stem (hfPS) cells. In: Masters JR and Palsson BO (eds) Human Adult Stem Cells, Human Cell Culture, vol. 7, pp. 171–182. Dordrecht: Springer.

Kobayashi HI, Man S, Grahm C et al. (1993) Acquired multicellular mediated resistance to alkylating agents in cancer. Proceedings of the National Academy of Sciences of the USA 90: 3294–3298.

Kubota T, Sasano N, Abe O et al. (1995) Potential of the histoculture drug response assay to contribute to cancer patient survival. Clinical Cancer Research 1: 1537–1543.

Leighton J (1951) A sponge matrix method for tissue culture; formation of organized aggregates of cells in vitro. Journal of the National Cancer Institute 12: 545–561.

Leighton J (1954) The growth patterns of some transplantable animal tumors in sponge matrix tissue culture. Journal of the National Cancer Institute 15: 275–293.

Leighton J, Justh G, Esper M and Kronenthal R (1967) Collagen‐coated cellulose sponge: three‐dimensional matrix for tissue culture of Walker tumor 256. Science 155: 1259–1261.

Li L and Hoffman RM (1995) Model of selective gene therapy of hair growth: liposome targeting of the active Lac‐Z gene to hair follicles of histocultured skin. In vitro Cellular & Developmental Biology 31A: 11–13.

Li L, Margolis LB and Hoffman RM (1991) Skin toxicity determined in vitro by three‐dimensional, native‐state histoculture. Proceedings of the National Academy of Sciences of the USA 88: 1908–1912.

Li L, Paus R, Margolis LB and Hoffman RM (1992) Hair growth in vitro from histocultured mouse skin. In vitro Cellular & Developmental Biology 28A: 479–481.

Miller BE, Miller FR and Heppner GH (1984) Assessing tumour drug sensitivity by a new in vitro assay which preserves tumour heterogeneity and subpopulation interactions. Journal of Cellular Physiology 3(Suppl.): 105–116.

Miller BE, Miller FR and Heppner GH (1985) Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Research 45: 4200–4205.

Pirnia F, Pawlak M, Thallinger GG et al. (2009) Novel functional profiling approach combining reverse phase protein microarrays and human 3‐D ex vivo tissue cultures: expression of apoptosis‐related proteins in human colon cancer. Proteomics 9: 3535–3548.

Singh B, Li R, Xu L et al. (2002) Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head & Neck 24: 437–442.

St Croix B, Florenes VA, Rak JW et al. (1996) Impact of the cyclin‐dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nature Medicine 2(11): 1204–1210.

Teicher BA, Herman TS, Holden S et al. (1990) Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 247: 1457–1461.

Further Reading

Chuu JJ, Liu JM, Tsou MH et al. (2007) Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas. Journal of Biomedical Science 14: 233–244.

Flowers JL, Hoffman RM, Driscoll TA et al. (2003) The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pH. Cancer Chemotherapy and Pharmacology 52: 253–261.

Fujita Y, Hiramatsu M, Kawai M et al. (2009) Histoculture drug response assay predicts the postoperative prognosis of patients with esophageal cancer. Oncology Reports 21: 499–505.

Gan Y, Wientjes MG, Badalament RA and Au JL (1996) Pharmacodynamics of doxorubicin in human bladder tumours. Clinical Cancer Research 2(8): 1275–1283.

Geller J, Partido C, Sionit L et al. (1997) Comparison of androgen‐independent growth and androgen‐dependent growth in BPH and cancer tissue from the same radical prostatectomies in sponge‐gel matrix histoculture. Prostate 31: 250–254.

Hoffman RM (1991) Three‐dimensional histoculture: origins and applications in cancer research. Cancer Cells 3: 86–92.

Hoffman RM (2005) The multiple uses of fluorescent proteins to visualize cancer in vivo. Nature Reviews. Cancer 5: 796–806.

Hoffman RM, Isobe Y, Kubota T et al. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Investigational New Drugs 17: 343–359.

Kim JC, Kim DD, Lee YM et al. (2009) Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay. International Journal of Colorectal Disease 24: 209–218.

Lee SW, Kim YM, Kim MB et al. (2009) Chemosensitivity of uterine cervical cancer demonstrated by the histoculture drug response assay. Tohoku Journal of Experimental Medicine 219: 277–282.

Li L, Paus R, Margolis LB and Hoffman RM (1992a) Hair shaft elongation, follicle growth and spontaneous regression in long‐term, sponge‐gel supported histoculture of human scalp skin. Proceedings of the National Academy of Sciences of the USA 89: 8764–8768.

Li L, Paus R, Slominski A and Hoffman RM (1992b) Skin histoculture assay for studying the hair cycle. In vitro Cellular & Developmental Biology 28A: 695–698.

Olbina G, Miljkovic D, Hoffman RM and Geller J (1998) New sensitive discovery histoculture model for growth‐inhibition studies in prostate cancer and BPH. Prostate 37: 126–129.

Yoshimasu T, Ohta F, Oura S et al. (2009) Histoculture drug response assay for gefitinib in non‐small‐cell lung cancer. General Thoracic and Cardiovascular Surgery 57: 138–143.

Yoshimasu T, Oura S, Hirai I et al. (2007) Data acquisition for the histoculture drug response assay in lung cancer. Journal of Thoracic and Cardiovascular Surgery 133: 303–308.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Hoffman, Robert M(Oct 2010) Histocultures and Their Use. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0002573.pub2]